A selective peroxisome proliferator-activated receptor-γ (PPARγ) modulator blocks adipocyte differentiation but stimulates glucose uptake in 3T3-L1 adipocytes

Molecular Endocrinology

Volumn 14, Issue 9, 2000, Pages 1425-1433

  Mukherjee, Ranjan ^a,b   Hoener, Patricia A ^a   Jow, Lily ^a   Bilakovics, James ^a   Klausing, Kay ^a   Mais, Dale E ^a   Faulkner, Amy ^a   Croston, Glenn E ^a,c   Paterniti Jr , James R ^a  

^a LIGAND PHARMACEUTICALS INC   (United States)

^b DUPONT COMPANY   (United States)

^c ACADIA PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [(5,5,8,8 TETRAMETHYL 5,6,7,8 TETRAHYDRO 2 NAPHTHYL)CARBONYL]BENZOIC ACID; 2,4 THIAZOLIDINEDIONE DERIVATIVE; BENZOIC ACID DERIVATIVE; DEXAMETHASONE; GW 2331; INSULIN; ISOBUTYLMETHYLXANTHINE; LG 100641; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; ROSIGLITAZONE; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; COMPETITIVE INHIBITION; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; GLUCOSE TRANSPORT; NONHUMAN; PRIORITY JOURNAL;

EID: 0033766035     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.14.9.0528     Document Type: Article

References (35)

1. Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors
2. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors
3. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ)
4. The structure-activity relationship between peroxisome proliferator-activated receptor γ agonism and the antihyperglycemic activity of thiazolidinediones
5. Spontaneous heritable changes leading to increased adipose conversion in 3T3 cells
6. Expression of insulin receptors during preadipocyte differentiation
7. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor
8. Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-γ: Binding and activation correlate with antidiabetic actions in db/db mice
9. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists
10. Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells
11. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma
12. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily
13. Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators
14. Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat
15. Synthesis of retinoid X receptor-specific ligands that are potent inducers of adipogenesis in 3T3-L1 cells
16. Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARγ2 versus PPARγ1 and activation with retinoid X receptor agonists and antagonists
17. New oral thiazolidinedione antidiabetic agents act as insulin sensitizers
18. TNF-α-induced insulin resistance in vivo and its prevention by troglitazone
19. Troglitazone enhances differentiation, basal glucose uptake, and Glut1 protein levels in 3T3-L1 adipocytes
20. Tumor necrosis factor-α does not cause insulin resistance in muscle
21. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-α
22. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins
23. A peroxisome proliferator-activated receptor γ ligand inhibits adipocyte differentiation
24. The PPARs: Transcriptional links to obesity, diabetes and cardiovascular disease
25. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation
26. 15-Deoxy-δ12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
27. Primary prevention of diabetes mellitus by prevention of obesity in monkeys
28. Characterization of synthetic tritium-labeled peroxisome proliferator-activated receptor (hPPAR-γ) ligand
29. Relationship between the inhibition constant (ki), the concentration of inhibitor which causes a 50 percent inhibition (IC50) of an enzymatic reaction
30. Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators
31. Nuclear receptor that identifies a novel retinoic acid response pathway
32. Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling
33. Differential regulation of peroxisome proliferator activated receptor γ1 (PPARγ1) and PPARγ2 messenger RNA expression in the early stages of adipogenesis